Segall Bryant & Hamill LLC Purchases Shares of 11,535 Utah Medical Products, Inc. $UTMD

Segall Bryant & Hamill LLC purchased a new stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 11,535 shares of the medical instruments supplier’s stock, valued at approximately $726,000. Segall Bryant & Hamill LLC owned about 0.36% of Utah Medical Products at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. First Horizon Advisors Inc. raised its stake in Utah Medical Products by 159.7% during the second quarter. First Horizon Advisors Inc. now owns 587 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 361 shares during the last quarter. CWM LLC raised its stake in Utah Medical Products by 60.4% during the 3rd quarter. CWM LLC now owns 1,330 shares of the medical instruments supplier’s stock valued at $84,000 after buying an additional 501 shares during the last quarter. Cornerstone Planning Group LLC increased its position in shares of Utah Medical Products by 3,272.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,349 shares of the medical instruments supplier’s stock valued at $85,000 after purchasing an additional 1,309 shares during the last quarter. State of Wyoming bought a new stake in shares of Utah Medical Products during the 2nd quarter valued at $132,000. Finally, Russell Investments Group Ltd. lifted its position in shares of Utah Medical Products by 550.5% during the 2nd quarter. Russell Investments Group Ltd. now owns 2,758 shares of the medical instruments supplier’s stock valued at $157,000 after buying an additional 2,334 shares in the last quarter. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised Utah Medical Products from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, February 25th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, Utah Medical Products currently has an average rating of “Hold”.

Utah Medical Products Price Performance

Shares of UTMD stock opened at $65.12 on Friday. The stock’s 50-day moving average is $62.23 and its 200 day moving average is $60.28. Utah Medical Products, Inc. has a 1-year low of $51.26 and a 1-year high of $68.71. The company has a market cap of $208.38 million, a P/E ratio of 18.71 and a beta of 0.33.

Utah Medical Products (NASDAQ:UTMD) last announced its quarterly earnings data on Thursday, January 29th. The medical instruments supplier reported $0.80 EPS for the quarter. Utah Medical Products had a net margin of 29.30% and a return on equity of 9.60%. The business had revenue of $9.04 million during the quarter.

Utah Medical Products Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 3rd. Shareholders of record on Tuesday, March 17th will be paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, March 17th. Utah Medical Products’s dividend payout ratio (DPR) is 35.63%.

Utah Medical Products Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).